HYPR — Hyperfine, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1833769 ·
Last close
$0.94
Market Cap
$85.54M
52W High
$2.22
52W Low
$0.75
ADV30
852,351
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,904,000 | 1,980,000 | -8,469,000 | -9,298,000 | 62,999,000 | 43,458,000 | 26,241,000 |
| Mar 2026 | 3,903,000 | 1,979,000 | -8,558,000 | -8,623,000 | 60,339,000 | 40,778,000 | 25,978,000 |
| Dec 2025 | 5,293,000 | 2,694,000 | -7,668,000 | -5,912,000 | 55,262,000 | 35,085,000 | 14,257,000 |
| Sep 2025 | 3,437,000 | 1,848,000 | -8,920,000 | -11,019,000 | 41,511,000 | 21,564,000 | 14,639,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-27,065,000
Investing CF
$-465,000
Financing CF
$46,716,000
CapEx
$-465,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.38
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-347,937,000
Inventory
$6,789,000
Receivables
$5,789,000
ST Investments
—
EBIT TTM
$-33,893,000
Pretax Income TTM
$-34,852,000
Interest Exp TTM
$616,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,537,000
EBITDA
$-32,499,000
Free Cash Flow
$-17,161,376
Enterprise Value
$53,744,052
Total Cash
$43,458,000
Total Debt
$13,413,000
Shares Out
90,993,381
Trailing EPS
$-0.37
Book Value
$0.35
ROE
-97.0%
ROA
-38.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,563,000 | -37,085,000 | -35,574,000 | 55,262,000 | 14,257,000 | 41,005,000 | -27,948,000 |
| Dec 2024 | 12,890,000 | -43,224,000 | -40,720,000 | 58,901,000 | 9,861,000 | 49,040,000 | -38,767,000 |
| Dec 2023 | 11,032,000 | -48,115,000 | -44,238,000 | 94,199,000 | 9,800,000 | 84,399,000 | -41,809,000 |
| Dec 2022 | 6,814,000 | -73,874,000 | -73,164,000 | 134,051,000 | 10,329,000 | 123,722,000 | -72,339,000 |
TTM Snapshot
Revenues TTM
$15,329,000
NetIncome TTM
$-34,779,000
OpCashFlow TTM
—
Assets (Latest)
$60,339,000
Forward EPS
$-0.32
Max Pain — expiry 2027-04-16
max pain strike: $1.00 · spot: $0.94 · call oi: 1,477 · put oi: 103
Expected Move to 2027-04-16:
±$0.46
(48.94%) —
implied range
$0.48 –
$1.40
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ECOR | electroCore, Inc. | $85.74M | $9.51 | — |
| NRXS | Neuraxis, INC | $85.02M | $6.77 | — |
| LNSR | LENSAR, Inc. | $79.24M | $6.45 | — |
| LUNG | Pulmonx Corp | $77.74M | $1.81 | — |
| QTEX | QTREX Quantum Ltd. | $94.15M | $1.69 | — |
News headlines (Yahoo Finance, 1h cache)
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
2026-10-08 12:33 · Yahoo
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
2026-10-08 11:30 · Yahoo
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
2026-09-16 12:00 · Yahoo
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
2026-09-15 12:15 · Yahoo
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
2026-08-31 12:15 · Yahoo
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
2026-08-20 12:15 · Yahoo
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript
2026-08-14 00:16 · Yahoo
Hyperfine Q2 Earnings Call Highlights
2026-08-07 03:03 · Yahoo
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
2026-08-06 23:10 · Yahoo
Hyperfine launches next-generation Swoop MRI system in Europe
2026-07-02 08:39 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.